Latest Breaking News On - இரசாயன கூறுகள் - Page 9 : comparemela.com

Granules India announced today that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India, for Potassium Chloride Oral Solution USP, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%). It is bioequivalent to the reference listed drug product (RLD), Potassium Chloride Oral Solution, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), of Genus Lifesciences, Inc. The product would be available in bottle of 473 ml and is expected to be launched shortly. Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose

Granules pharmaceuticals incUs food drug administrationGenus lifesciences incGranules indiaDrug administrationAbbreviated new drug applicationGranules pharmaceuticalsPotassium chloride oral solutionGenus lifesciencesChloride oralCapital marketPhysical sciencesChemical elementsDietary mineralsElectrolyte disturbancesMetal halides